EGF Theramed Health Corp.

TMED

CA2684692023

Biotechnology & Medical Research

Market Closed - Canadian Securities Exchange Other stock markets 14:56:38 16/05/2024 BST			5-day change	1st Jan Change
0.145 ^CAD	+3.57%		+3.57%	-23.68%

02-26	EGF Theramed Health Corp. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	CI
2023	EGF Theramed Health Corp. Reports Earnings Results for the First Quarter Ended September 30, 2023	CI

EGF Theramed Health Corp. Announces Resignation of Jatinder Dhaliwal as Director

August 18, 2022 at 09:19 pm

EGF Theramed Health Corp. announced that Mr. Jatinder Dhaliwal has resigned from his director role.

Latest news about EGF Theramed Health Corp.

EGF Theramed Health Corp. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	02-26	CI
EGF Theramed Health Corp. Reports Earnings Results for the First Quarter Ended September 30, 2023	11-27	CI
EGF Theramed Health Corp. entered into a Letter of Intent to acquire Nanaimo Dispensary from Kiaro Holdings Corp. (TSXV:KO) for CAD 0.12 million.	29/10/23	CI
EGF Theramed Health Corp. Reports Earnings Results for the Full Year Ended June 30, 2023	29/10/23	CI
EGF Theramed Health Corp. Announces Board Changes	07/07/23	CI
EGF Theramed Health Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	29/05/23	CI
EGF Theramed Health Corp. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	27/02/23	CI
EGF Theramed Health Corp. Reports Earnings Results for the First Quarter Ended September 30, 2022	29/11/22	CI
EGF Theramed Health Corp. Reports Earnings Results for the Full Year Ended June 30, 2022	29/10/22	CI
EGF Theramed Health Corp. Auditor Raises 'Going Concern' Doubt	27/10/22	CI
EGF Theramed Health Corp. Announces Resignation of Jatinder Dhaliwal as Director	18/08/22	CI
EGF Theramed Health Corp. Announces Executive Changes	18/08/22	CI
EGF Theramed Health Corp. entered into a term sheet to acquire Reefer Keeper Delivery Corp. for CAD 0.96 million.	16/08/22	CI
EGF Theramed Health Corp. announced that it has received CAD 0.5 million in funding	21/07/22	CI
EGF Theramed Health Corp. announced that it expects to receive CAD 0.5 million in funding	17/07/22	CI
EGF Theramed Health Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022	30/05/22	CI
EGF Theramed Health Corp. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021	27/02/22	CI
EGF Theramed Health Corp. Auditor Raises 'Going Concern' Doubt	31/10/21	CI
EGF Theramed Health Corp. Auditor Raises 'Going Concern' Doubt	19/08/21	CI
EGF Theramed Health Corp. announced that it has received CAD 0.25 million in funding	13/07/21	CI
EGF Theramed Health Corp. announced that it expects to receive CAD 0.4 million in funding	27/06/21	CI
EGF Theramed Health Corp. announced that it has received CAD 0.2 million in funding	22/06/21	CI
Seedadelic Med Corp. completed the acquisition of EGF Theramed Health Corp. in a reverse merger transaction.	06/06/21	CI
EGF Theramed Health Corp. announced that it expects to receive CAD 0.2 million in funding	02/06/21	CI
Egf Theramed Health Corp. Reports Earnings Results for the Third Quarter Ended March 31, 2021	30/05/21	CI

Chart EGF Theramed Health Corp.

Duration

Period

More charts

EGF Theramed Health Corp. is a Canada-based consumer technology company engaged in the provision of biomedical online services for monitoring and treating common health problems. The Company, through its subsidiaries, has assets and technologies used in the extraction and purification of botanical extracts and the creation of extract formulations, as well as medical monitoring device technology. The Company is working to collaborate with other companies for medical technology, equipment protocols and laboratory SOPs. The Company is focused on developing products, technologies, and diagnostic tools in personalized medical care areas, including research with natural health and wellness products. The Company is focused on the health care and life sciences sector to develop a personalized health care system. The Company is also exploring opportunities in all medical areas in domestic and international markets. Its portfolio includes Pharmadelic Labs and Green Parrot Labs.

Sector

Biotechnology & Medical Research

Calendar

27/05/2024 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
EGF THERAMED HEALTH CORP.	-23.68%	1.17M
MODERNA, INC.	+41.79%	50.93B
IQVIA HOLDINGS INC.	-0.56%	42.12B
LONZA GROUP AG	+49.62%	42.05B
CELLTRION, INC.	-7.20%	29.18B
ICON PUBLIC LIMITED COMPANY	+12.59%	26.02B
ALNYLAM PHARMACEUTICALS, INC.	-21.51%	18.9B
BIO-TECHNE CORPORATION	+6.92%	13.21B
UNITED THERAPEUTICS CORPORATION	+24.91%	12.17B
MEDPACE HOLDINGS, INC.	+29.60%	12.16B